DEPO Depomed, Inc.

10.39
-0.24  -2%
Previous Close 10.63
Open 10.61
Price To book 2.88
Market Cap 647.72M
Shares 62,341,000
Volume 1,356,455
Short Ratio 8.14
Av. Daily Volume 1,616,460

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 28, 2011.
GRALISE
Postherpetic neuralgia - shingles
CRL issued May 31, 2013.
SEFELSA
Hot flashes

Latest News

  1. Teva Pharma, Eagle Pharma, Depomed Among Slew Getting Price Haircuts
  2. Biotech And Pharma Industry And Stock News
  3. Depomed Announces Corporate Governance Updates
  4. Depomed to Present at the UBS Global Healthcare Conference
  5. Today's Research Reports on Stocks to Watch: Rexahn Pharmaceuticals and Depomed
  6. Edited Transcript of DEPO earnings conference call or presentation 9-May-17 8:30pm GMT
  7. Depomed Focuses on Flagship Drug Rather Than M&A: CEO
  8. Biotech Movers: Depomed Shares Tank After Losses Get Even Worse
  9. Analysts' Actions -- Allergan, Coach, General Dynamics, Occidental and More
  10. Depomed reports 1Q loss
  11. Depomed shares down 13% after earnings miss
  12. Depomed Announces First Quarter 2017 Financial Results and Strategic Initiatives Aimed at Driving Sustainable Long-Term Growth and Shareholder Value
  13. Investor Network: Depomed, Inc. to Host Earnings Call
  14. One Year Later: A Look At The 2016 Ira Sohn Conference Picks
  15. Depomed to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017
  16. Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and Administration
  17. Which Drugmakers Will Rock The Sector In Q1?
  18. STRATA Skin Sciences and Depomed Recover from Wednesday's FDA Opioid Shockwave
  19. DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control
  20. Depomed Announces Prepayment of $100 Million of Secured Debt Facility